glucagon in retatrutide Diagram showing the mechanism of action of Retatrutide: The "Triple G" Peptide

The loss of one allele of Kat6a causes isolated cardiac septum defects with 10% penetrance (Voss et al, 2012)

[1] [2] This trial enrolled adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity the primary cohort was largely without type 2 diabetes and assessed multiple doses of retatrutide against placebo over 24 weeks, with an extension to 48 weeks

If you want to build flexibility in your hips, I have a 4 week training program inside the Lax Goalie Rat Academy

Moderate Scarring Protocol For multiple boxcar or rolling scars of moderate depth, more intensive intervention produces better results

GLP-1 medications on their own carry a low risk of hypoglycemia in non-diabetic patients

6 Microdosing could offer a solution, with lower doses helping maintain some of the benefits (such as appetite regulation) and preventing weight regain after reaching weight-loss goals